Search by Drug Name or NDC

    NDC 60505-6151-04 Ceftriaxone Sodium 250 mg/1 Details

    Ceftriaxone Sodium 250 mg/1

    Ceftriaxone Sodium is a INTRAMUSCULAR; INTRAVENOUS INJECTION, POWDER, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Apotex Corp.. The primary component is CEFTRIAXONE SODIUM.

    Product Information

    NDC 60505-6151
    Product ID 60505-6151_0432e6c3-ad77-726c-e063-6294a90a798c
    Associated GPIs 02300090102105
    GCN Sequence Number 009165
    GCN Sequence Number Description ceftriaxone sodium VIAL 250 MG INJECTION
    HIC3 W1Y
    HIC3 Description CEPHALOSPORIN ANTIBIOTICS - 3RD GENERATION
    GCN 39960
    HICL Sequence Number 003996
    HICL Sequence Number Description CEFTRIAXONE SODIUM
    Brand/Generic Generic
    Proprietary Name Ceftriaxone Sodium
    Proprietary Name Suffix n/a
    Non-Proprietary Name Ceftriaxone Sodium
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, POWDER, FOR SOLUTION
    Route INTRAMUSCULAR; INTRAVENOUS
    Active Ingredient Strength 250
    Active Ingredient Units mg/1
    Substance Name CEFTRIAXONE SODIUM
    Labeler Name Apotex Corp.
    Pharmaceutical Class Cephalosporin Antibacterial [EPC], Cephalosporins [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA203702
    Listing Certified Through 2024-12-31

    Package

    NDC 60505-6151-04 (60505615104)

    NDC Package Code 60505-6151-4
    Billing NDC 60505615104
    Package 1 VIAL, SINGLE-USE in 1 CARTON (60505-6151-4) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-USE
    Marketing Start Date 2017-06-30
    NDC Exclude Flag N
    Pricing Information N/A